SPONSORED BY

Auto Segment
Mutual Fund Segment
My Budget
Expert Speak
In Association With
 
Business Standard

Sun Pharma at new high on FDA nod for generic version of Januvia

USFDA has granted its subsidiary, two tentative approvals for its ANDA for generic version of Januvia, Sitagliptin tablets and generic version of Glumetza, Metformin HCl extended-release tablets.

Related News

Sun Pharmaceutical Industries has moved higher by 3% to Rs 914, extending its previous day’s 2.3% gain after the company said it has received a tentative approval from the US drug regulator for generic version of Januvia.

The stock opened at Rs 886 and hit a new high of Rs 920 on NSE. The trading volumes on the counter more than doubled with a  combined 699,849 shares changing hands till 1141 hours on NSE and BSE.

On Monday, said that the US Food and Drugs Administration (USFDA) has granted its subsidiary, two tentative approvals for its Abbreviated New Drug Applications (ANDA) for generic version of Januvia, Sitagliptin tablets and generic version of Glumetza, Metformin HCl extended-release tablets.

Sitagliptin tablets have annual sales of approximately US$ 2.7 billion, while Metformin HCl Extended-release tablets have annual sales of approximately US$ 140 million in the US, it added.

Sitagliptin tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type-2 diabetes mellitus. Metformin HCl Extended-release tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type-2 diabetes mellitus.
 

Read more on:   
|
|

Read More

Fresenius Kabi Oncology soars on delisting plan

The promoter intends to pay an indicative price of Rs 130 per share to acquire the shares offered to it in the Delisting Offer

Recommended for you

Quick Links

Market News

Budget Impact : ITC dips 9% after excise duty hike on cigarettes

The stock has fallen nearly 13% from its record high of Rs 410 touched on NSE during intra-day trade today.

Footwear makers gain on reduction in excise duty

Liberty Shoes, Bata India, Relaxo Footwears and Mirza International were up 2-6% on BSE.

Jaitley says will merge regulators Sebi and FMC

The merger of the commodities and equtiy markets regulators had been hinted at in the Economic Survey

Budget Impact: MCX hits 52-week high

The stock has rallied nearly 9% to Rs 1,144 on the BSE

NBCC gains on signing MoU with Delhi Development Authority

The stock up 4% at Rs 888 on BSE.

 

Back to Top